OTC Markets Group Reports Fourth Quarter and Full Year 2023 Results Delivering Continued Revenue Growth
- Gross revenues increased by 5% to $109.9 million in 2023.
- Operating income decreased by 11% to $32.6 million in 2023.
- Net income declined by 10% to $27.7 million in 2023.
- The company announced a dividend of $0.18 per share for the first quarter of 2024.
- Julia Sears was appointed to the OTC Markets Group Board of Directors.
- Operating income and net income decreased in 2023 compared to 2022.
- Expenses outpaced the increase in revenues, impacting operating margin and net income.
- OTC Link revenues declined by 6% in 2023.
- Market Data Licensing revenues grew by 19% in 2023.
Fourth Quarter and Full Year 2023 Highlights:
- Gross revenues of
$109.9 million for the year, up5% versus 2022 - Operating income of
$32.6 million for the year, down11% versus 2022 - Operating profit margin of
30.6% for the year, versus36.1% for 2022 - Net income of
$27.7 million for 2023, down10% versus 2022, and GAAP diluted EPS of$2.28 versus$2.53 for 2022 - Total cash returned to shareholders during 2023 of
$29.9 million , comprised of dividends of$26.5 million and repurchases of common shares of$3.4 million , up3% versus 2022 - Announcing first quarter 2024 dividend of
$0.18 per share - 600 OTCQX® and 1,140 OTCQB® companies at year end
- 38 graduates to a national securities exchange during 2023
- 108 subscribers to OTC Link ECN as of year-end 2023, up 6 versus 2022
- 136 unique OTC Link subscribers, up 3 versus 2022
- Approximately 32,000 average daily trades during 2023 versus approximately 36,000 during 2022
- Fourth quarter gross revenues of
$27.6 million , up1% versus the prior year quarter - Fourth quarter operating income of
$8.8 million , down11% versus the prior year quarter - Fourth quarter operating profit margin of
32.8% , as compared to37.2% in the prior year quarter - Continued progress in achieving state Blue Sky recognition for our OTCQX and OTCQB markets, with exemptions in 39 states and one U.S. territory as of March 1, 2024
- OTC market data feeds available on Nasdaq’s Data Link platform
- Julia Sears appointed to OTC Markets Group Board of Directors
NEW YORK, March 06, 2024 (GLOBE NEWSWIRE) -- OTC Markets Group Inc. (OTCQX: OTCM), operator of regulated markets for trading 12,000 U.S. and international securities, today announced its financial results for the fourth quarter and full year 2023.
“Following a year of acquisitions, we spent 2023 coming together as one team, on one platform, to build the value of one share,” said R. Cromwell Coulson, President and Chief Executive Officer. “As we turn to 2024, we remain committed to integrating our expanded data offerings and distribution capabilities to provide greater client value. By thoughtfully investing in our processes and platform, we can better empower broker-dealers and public companies to serve investors, and expand our markets.”
“During 2023, OTC Markets Group reached nearly
Fourth Quarter 2023 compared to Fourth Quarter 2022
Quarter Ended December 31, | ||||||||||||||
(in thousands, except shares and per share data) | 2023 | 2022 | % change | $ change | ||||||||||
OTC Link | $ | 4,802 | $ | 5,346 | (10 | %) | ( 544 | ) | ||||||
Market data licensing | 10,881 | 9,895 | 10 | % | 986 | |||||||||
Corporate services | 11,922 | 12,054 | (1 | %) | ( 132 | ) | ||||||||
Gross Revenues | 27,605 | 27,295 | 1 | % | 310 | |||||||||
Net revenues | 26,772 | 26,537 | 1 | % | 235 | |||||||||
Revenues less transaction-based expenses | 25,442 | 24,867 | 2 | % | 575 | |||||||||
Operating expenses | 16,651 | 14,990 | 11 | % | 1,661 | |||||||||
Income from operations | 8,791 | 9,877 | (11 | %) | ( 1,086 | ) | ||||||||
Operating profit margin | 32.8 | % | 37.2 | % | ||||||||||
Income before provision for income taxes | 9,065 | 10,031 | (10 | %) | ( 966 | ) | ||||||||
Net income | $ | 7,001 | $ | 8,630 | (19 | %) | ( 1,629 | ) | ||||||
Diluted earnings per share | $ | 0.58 | $ | 0.70 | (18 | %) | ||||||||
Adjusted diluted earnings per share | $ | 0.89 | $ | 0.95 | (7 | %) | ||||||||
Weighted-average shares outstanding, diluted | 11,874,331 | 11,895,058 | (0 | %) | ||||||||||
Fourth Quarter 2023 Financial Highlights
- Gross revenues of
$27.6 million , up1% over the prior year quarter. Revenues less transaction-based expenses up2% . - OTC Link revenues down
10% . Transaction-based revenues from OTC Link ECN and OTC Link NQB down16% , reflecting the impact of lower trading volumes on these platforms, which more than offset the effect of increases in certain fees. Reduced trading activity on OTC Link ATS resulted in messages revenue declining11% and QAP One Statement fees declining19% , which further contributed to the overall decline in OTC Link revenues. - Market Data Licensing revenues up
10% , due to a full quarter contribution of the November 2022 acquisition of EDGAR Online as well as subscriber growth and price increases for certain licenses. Pro-user revenues were up7% , in line with a6% increase in the number of professional users quarter over quarter. Revenues from non-pro users were down22% , driven by a20% decrease in the number of non-pro users of our market data. Revenues from market data connectivity fees increased68% and revenues from internal system licenses, delayed data licenses, and certain other data services increased5% , in each case due to growth in subscribers and price increases for certain licenses. - Corporate Services revenues down
1% quarter over quarter, with a4% increase in revenues from our OTCQX market, offset by a5% decrease each in revenues from the OTCQB market and the Disclosure & News Service® (“DNS”) product. A lower average number of companies on our OTCQB market as well as of companies subscribing to DNS during the quarter impacted the revenues for these products, offsetting the annual, incremental price increases effective at the beginning of 2023. Partially offsetting the decline in Corporate Services revenues was higher revenue from our Virtual Investor Conferences® (“VIC”) product due to a greater number of events held during the quarter, and higher revenue from the OTCIQ Basic product. - Operating expenses increased
11% over the prior year quarter. The increase was primarily driven by a69% increase in professional and consulting costs, largely as a result of an accrual related to an SEC matter. Further contributing to the growth in operating expenses was a6% increase in compensation and benefits costs, reflecting a higher average headcount during the quarter. - Operating income and net income decreased
11% to$8.8 million and19% to$7.0 million , respectively. - Adjusted EBITDA, which excludes non-cash stock-based compensation expense, decreased
7% to$10.8 million , or$0.89 per adjusted diluted share.
Fiscal Year 2023 Results compared to Fiscal Year 2022
Year Ended December 31, | ||||||||||||||
(in thousands, except shares and per share data) | 2023 | 2022 | % change | $ change | ||||||||||
OTC Link | $ | 19,599 | $ | 20,937 | (6 | %) | ( 1,338 | ) | ||||||
Market data licensing | 43,368 | 36,407 | 19 | % | 6,961 | |||||||||
Corporate services | 46,928 | 47,805 | (2 | %) | ( 877 | ) | ||||||||
Gross Revenues | 109,895 | 105,149 | 5 | % | 4,746 | |||||||||
Net revenues | 106,658 | 102,048 | 5 | % | 4,610 | |||||||||
Revenues less transaction-based expenses | 101,134 | 96,201 | 5 | % | 4,933 | |||||||||
Operating expenses | 68,540 | 59,380 | 15 | % | 9,160 | |||||||||
Income from operations | 32,594 | 36,821 | (11 | %) | ( 4,227 | ) | ||||||||
Operating profit margin | 30.6 | % | 36.1 | % | ||||||||||
Income before provision for income taxes | 33,497 | 36,966 | (9 | %) | ( 3,469 | ) | ||||||||
Net income | $ | 27,661 | $ | 30,814 | (10 | %) | ( 3,153 | ) | ||||||
Diluted earnings per share | $ | 2.28 | $ | 2.53 | (10 | %) | ||||||||
Adjusted diluted earnings per share | $ | 3.37 | $ | 3.56 | (5 | %) | ||||||||
Weighted-average shares outstanding, diluted | 11,863,180 | 11,887,868 | (0 | %) | ||||||||||
Fiscal Year 2023 Financial Highlights
- Gross revenues of
$109.9 million , up5% . Revenues less transaction-based expenses up5% . - OTC Link revenues down
6% , primarily as a result of a reduction in revenues from OTC Link ATS messages of18% and from OTC Link ECN and OTC Link NQB, which in aggregate declined5% . Contributing to the overall decline in OTC Link revenues were also QAP One Statement fees, down31% . The decline in OTC Link revenues is consistent with a year over year decline in trading activity on our markets. - Market Data Licensing revenues up
19% , inclusive of the full year impact of the acquisitions of Blue Sky Data Corp and EDGAR Online. Excluding the impact of the acquisitions, Market Data Licensing revenues grew approximately7% , due to5% growth in revenues from professional user licenses,67% growth in revenues from market data connectivity fees, and9% growth in internal system licenses, delayed data licenses and certain other data services, offsetting a27% decline in revenues from non-professional users. - Corporate Services revenues down
2% . OTCQX revenues up3% due to price increases and a relatively unchanged average number of companies on the OTCQX market. OTCQB and DNS revenues down3% and7% , respectively, due to a lower number of companies subscribing to OTCQB and DNS, more than offsetting the impact of pricing adjustments. Lower revenues from VIC, due to fewer events held during 2023, also contributed to the overall decline in Corporate Services revenues, but were partially offset by growth in revenues from OTCIQ Basic. - Operating expenses were up
$9.2 million , or15% , reflecting a13% increase in compensation and benefits as a result of higher average headcount, a27% increase in IT infrastructure and information services costs, primarily as a result of our acquisitions, and a25% increase in professional and consulting fees, primarily as a result of regulatory and legal costs related to an SEC matter. Operating expenses include approximately$1.1 million in one-time, non-recurring costs related to EDGAR Online, and approximately$1.4 million in costs related to the SEC matter. - Operating income decreased
11% to$32.6 million and net income decreased10% to$27.7 million . - Adjusted EBITDA declined
5% to$40.9 million , or$3.37 per adjusted diluted share.
Dividend Declaration – Quarterly Cash Dividend
OTC Markets Group announced today that its Board of Directors authorized and approved a quarterly cash dividend of
Stock Buyback Program
The Company is authorized to purchase shares from time to time on the open market, from employees and through block trades, in compliance with applicable law.
On March 4, 2024, the Board of Directors refreshed the Company’s stock repurchase program, giving the Company authorization to repurchase up to 300,000 shares of the Company’s Class A Common Stock.
Non-GAAP Financial Measures
In addition to disclosing results prepared in accordance with GAAP, the Company also discloses certain non-GAAP results of operations, including adjusted EBITDA and adjusted diluted earnings per share that either exclude or include amounts that are described in the reconciliation table of GAAP to non-GAAP information provided at the end of this release. Non-GAAP financial measures do not replace and are not superior to the presentation of GAAP financial results but are provided to improve overall understanding of the Company’s current financial performance. Management believes that this non-GAAP information is useful to both management and investors regarding certain additional financial and business trends related to the operating results. Management uses this non-GAAP information, along with GAAP information, in evaluating its historical operating performance.
Fourth Quarter and Full Year 2023 Conference Call
The Company will host a conference call and webcast on Thursday, March 7, 2024, at 8:30 a.m. Eastern Time, during which management will discuss the financial results in further detail. The call and webcast may be accessed as follows:
Webcast:
The conference webcast and management presentation can be accessed at the following link (replay available until March 6, 2025):
https://edge.media-server.com/mmc/p/rhwuud87
Live Call:
Participants intending to ask a question during the live call and Q&A session should also register in advance at:
https://register.vevent.com/register/BI142d90b57b7545e7bf967bd2ba364a54
Upon registration, participants will receive a dial-in number along with a unique PIN number that can be used to access the live call. Live call participants may also select a “Call Me” option.
OTC Markets Group’s Annual Report, earnings release, transcript of the earnings call, and management presentation will also be available in the Investor Relations section of our corporate website at www.otcmarkets.com/investor-relations/overview.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market, and Pink® Open Market.
Our OTC Link® Alternative Trading Systems (ATSs) provide critical market infrastructure that broker-dealers rely on to facilitate trading. Our innovative model offers companies more efficient access to the U.S. financial markets.
OTC Link ATS, OTC Link ECN, and OTC Link NQB are each an SEC regulated ATS, operated by OTC Link LLC, a FINRA and SEC registered broker-dealer, member SIPC.
To learn more about how we create better informed and more efficient markets, visit www.otcmarkets.com.
Investor Contact:
Antonia Georgieva
Chief Financial Officer
Phone: (212) 220-2215
Email: ir@otcmarkets.com
Media Contact:
OTC Markets Group Inc.
Phone: (212) 896-4428
Email: media@otcmarkets.com
OTC MARKETS GROUP INC. | |||||||||||||||
CONDENSED CONSOLIDATED STATEMENTS OF INCOME | |||||||||||||||
(in thousands, except share and per share information) | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
OTC Link | $ | 4,802 | $ | 5,346 | $ | 19,599 | $ | 20,937 | |||||||
Market data licensing | 10,881 | 9,895 | 43,368 | 36,407 | |||||||||||
Corporate services | 11,922 | 12,054 | 46,928 | 47,805 | |||||||||||
Gross revenues | 27,605 | 27,295 | 109,895 | 105,149 | |||||||||||
Redistribution fees and rebates | (833 | ) | (758 | ) | (3,237 | ) | (3,101 | ) | |||||||
Net revenues | 26,772 | 26,537 | 106,658 | 102,048 | |||||||||||
Transaction-based expenses | (1,330 | ) | (1,670 | ) | (5,524 | ) | (5,847 | ) | |||||||
Revenues less transaction-based expenses | 25,442 | 24,867 | 101,134 | 96,201 | |||||||||||
Operating expenses | |||||||||||||||
Compensation and benefits | 9,460 | 8,887 | 42,467 | 37,585 | |||||||||||
IT Infrastructure and information services | 2,298 | 2,323 | 10,311 | 8,091 | |||||||||||
Professional and consulting fees | 3,077 | 1,817 | 8,048 | 6,464 | |||||||||||
Marketing and advertising | 315 | 351 | 1,194 | 1,303 | |||||||||||
Occupancy costs | 591 | 481 | 2,360 | 2,257 | |||||||||||
Depreciation and amortization | 554 | 600 | 2,398 | 2,092 | |||||||||||
General, administrative and other | 356 | 531 | 1,762 | 1,588 | |||||||||||
Total operating expenses | 16,651 | 14,990 | 68,540 | 59,380 | |||||||||||
Income from operations | 8,791 | 9,877 | 32,594 | 36,821 | |||||||||||
Other income | |||||||||||||||
Other income | 274 | 154 | 903 | 145 | |||||||||||
Income before provision for income taxes | 9,065 | 10,031 | 33,497 | 36,966 | |||||||||||
Provision for income taxes | 2,064 | 1,401 | 5,836 | 6,152 | |||||||||||
Net Income | $ | 7,001 | $ | 8,630 | $ | 27,661 | $ | 30,814 | |||||||
Earnings per share | |||||||||||||||
Basic | $ | 0.59 | $ | 0.73 | $ | 2.32 | $ | 2.60 | |||||||
Diluted | $ | 0.58 | $ | 0.70 | $ | 2.28 | $ | 2.53 | |||||||
Basic weighted average shares outstanding | 11,669,376 | 11,609,318 | 11,658,694 | 11,600,122 | |||||||||||
Diluted weighted average shares outstanding | 11,874,331 | 11,895,058 | 11,863,180 | 11,887,868 | |||||||||||
Non-GAAP Reconciliation | |||||||||||||||
Three Months Ended December 31, | Year Ended December 31, | ||||||||||||||
2023 | 2022 | 2023 | 2022 | ||||||||||||
Net Income | $ | 7,001 | $ | 8,630 | $ | 27,661 | $ | 30,814 | |||||||
Excluding: | |||||||||||||||
Interest Income | (312 | ) | (154 | ) | (844 | ) | (155 | ) | |||||||
Provision for income taxes | 2,064 | 1,401 | 5,836 | 6,152 | |||||||||||
Depreciation and amortization | 554 | 600 | 2,398 | 2,092 | |||||||||||
Stock-based compensation expense | 1,493 | 1,106 | 5,858 | 4,345 | |||||||||||
Adjusted EBITDA | $ | 10,800 | $ | 11,583 | $ | 40,909 | $ | 43,248 | |||||||
Adjusted diluted earnings per share | $ | 0.89 | $ | 0.95 | $ | 3.37 | $ | 3.56 | |||||||
Note: We use non-GAAP financial measures of operating performance. Non-GAAP measures do not replace and are not superior to the presentation of our GAAP financial results, but are provided to improve overall understanding of the Company's current financial performance. | |||||||||||||||
OTC MARKETS GROUP INC. | |||||||
CONSOLIDATED BALANCE SHEETS | |||||||
(in thousands, except share information) | |||||||
December 31, | |||||||
2023 | 2022 | ||||||
Assets | |||||||
Current assets | |||||||
Cash and cash equivalents | $ | 34,101 | $ | 37,368 | |||
Short-term investments | 3,622 | - | |||||
Accounts receivable, net of allowance for credit losses of | 7,680 | 9,485 | |||||
Prepaid income taxes | 1,324 | 59 | |||||
Prepaid expenses and other current assets | 1,865 | 1,469 | |||||
Total current assets | 48,592 | 48,381 | |||||
Property and equipment, net | 8,429 | 8,637 | |||||
Operating lease right-of-use assets | 12,324 | 13,635 | |||||
Deferred tax assets, net | 7,691 | 4,853 | |||||
Goodwill | 3,984 | 3,984 | |||||
Intangible assets, net | 7,411 | 7,993 | |||||
Long-term restricted cash | 1,586 | 1,568 | |||||
Other assets | 508 | 567 | |||||
Total Assets | $ | 90,525 | $ | 89,618 | |||
Liabilities and stockholders' equity | |||||||
Current liabilities | |||||||
Accounts payable | $ | 2,152 | $ | 1,684 | |||
Income taxes payable | 141 | 567 | |||||
Accrued expenses and other current liabilities | 14,065 | 13,141 | |||||
Deferred revenue | 29,267 | 30,456 | |||||
Total current liabilities | 45,625 | 45,848 | |||||
Income tax reserve | 778 | 657 | |||||
Operating lease liabilities | 11,895 | 13,309 | |||||
Total Liabilities | 58,298 | 59,814 | |||||
Commitments and contingencies | |||||||
Stockholders' equity | |||||||
Common stock - par value | |||||||
Class A - 17,000,000 authorized, 12,716,135 issued, 11,931,366 outstanding at December 31, 2023; 12,601,270 issued, 11,874,763 outstanding at December 31, 2022 | 127 | 126 | |||||
Additional paid-in capital | 29,469 | 24,847 | |||||
Retained earnings | 22,425 | 21,246 | |||||
Treasury stock - 784,769 shares at December 31, 2023 and 726,507 shares at December 31, 2022 | (19,794 | ) | (16,415 | ) | |||
Total Stockholders' Equity | 32,227 | 29,804 | |||||
Total Liabilities and Stockholders' Equity | $ | 90,525 | $ | 89,618 | |||
FAQ
What were the gross revenues for OTC Markets Group in 2023?
What was the operating income for OTC Markets Group in 2023?
What was the net income for OTC Markets Group in 2023?
What dividend did OTC Markets Group announce for the first quarter of 2024?